Article thumbnail

Right Ventricular Dysfunction and Failure in Chronic Pressure Overload

By Marc A. Simon and Michael R. Pinsky

Abstract

Right ventricular (RV) dysfunction is the main cause of death in pulmonary arterial hypertension (PAH). Our understanding of the pathophysiology of RV dysfunction is limited but improving. Methods to better diagnose RV dysfunction earlier and treatments specifically designed to minimize or reverse the remodeling process are likely to improve outcomes. We review the current understanding of RV dysfunction in chronic pressure overload and introduce some novel insights based on recent investigations into pathophysiology, diagnosis, and treatment

Topics: Review Article
Publisher: SAGE-Hindawi Access to Research
OAI identifier: oai:pubmedcentral.nih.gov:3087982
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2008). A dynamic and chamber-specific mitochondrial remodeling in right ventricular hypertrophy can be therapeutically targeted,”
  2. (2002). Accuracy of real-time three-dimensional echocardiography for quantifying right ventricular volume: static and pulsatile flow studies in an anatomic in vitro model,”
  3. (2005). Assessment of right ventricular function by 16-detector-row CT: comparison with magneticresonanceimaging,”European Radiology,
  4. (2009). Assessment of the right ventricle by echocardiography: a primer for cardiac sonographers,”
  5. (2009). Cardiac magnetic resonance imagingfor the assessmentof the heart and pulmonary circulation in pulmonary hypertension,”
  6. (1997). Changes in gene expression in the intact human heart: downregulation of α-myosin heavy chain in hypertrophied, failing ventricular myocardium,”
  7. (1951). Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure,”
  8. (2009). Comprehensive invasive and noninvasive approach to the right ventricle-pulmonary circulation unit state of the art and clinical and research implications,”
  9. (1991). D ’ A l o n z o ,R .J .B a r s t ,S .M .A y r e se ta l . ,“ S u r v i v a li n patients with primary pulmonary hypertension: results from a national prospective registry,”
  10. (2008). de Lemos et al., “Changes in right ventricular structure andfunction assessedusing cardiac magnetic resonance imaging in bosentan-treated patients with pulmonary arterial hypertension,”
  11. (2009). Diagnosis and assessment of pulmonary arterial hypertension,”
  12. (2002). e n z e l ,T .K r a m m ,A .B r¨ u c k n e r ,S .M o h r - K a h a l y ,E .M a y e r
  13. (1998). e v a ,A .J .P o w e l l ,E .C .C r a w f o r d ,T .C h u n g ,a n dS .D . Colan, “Evaluation of regional differences in right ventricular systolic function by acoustic quantification echocardiography and cine magnetic resonance imaging,”
  14. (2004). Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension,”
  15. (2009). Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance,”
  16. (2005). fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and6 Cardiology Research and Practice the effect of epoprostenol,”
  17. (2009). G h o f r a n i ,R .J .B a r s t ,R .L .B e n z ae ta l . ,“ F u t u r ep e r s p e c -tives for the treatment of pulmonary arterial hypertension,”
  18. (2009). H a n d o k o ,R .R .L a m b e r t s ,E .M .R e d o u te ta l . ,“ R i g h t ventricular pacing improves right heart function in experimental pulmonary arterial hypertension: a study in the isolated heart,”
  19. (1987). High-dose calcium channelblocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy,”
  20. (2007). How prostacyclin improves cardiac output in right heart failure in conjunction with pulmonary hypertension,”
  21. (2008). Identifying right ventricular dysfunction with tissue Doppler imaging in pulmonary hypertension,”
  22. (1997). J.Barstet al.,“Effects of longterm infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension,”
  23. (2006). Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil,”
  24. (2004). Magnetic resonance imaging analysis of right ventricular pressure-volume loops: in vivo validation and clinical application in patients with pulmonary hypertension,”
  25. (2008). Magnetic resonancederived 3-dimensional blood flow patterns in the main pulmonary artery as a marker of pulmonary hypertension and a measure of elevated mean pulmonary arterial pressure,”
  26. (2010). Medical and surgical treatment of acute right ventricular failure,”
  27. (2007). Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines,”
  28. (2009). Mitochondrial nitric oxide metabolism during rat heart adaptation to high altitude: effect of sildenafil, L-NAME, and L-arginine treatments,”
  29. (2009). Mitochondrial NOS is upregulated inthehypoxicheart:implicationsforthefunction of the hypertrophied right ventricle,”
  30. (2006). Multi-detector row cardiac computed tomography accurately quantifies right and left ventricular size and function compared with cardiac magnetic resonance,”
  31. (2009). Ozyeretal.,“Tissuedopplerstudy of the right ventricle with a multisegmental approach: comparison with cardiac magnetic resonance imaging,”
  32. (2009). Phenotyping the right ventricle in patients with pulmonary hypertension,”
  33. (2007). Phosphodiesterasetype 5ishighlyexpressed inthehypertrophied human right ventricle,andacute inhibitionofphosphodiesterasetype 5 improves contractility,”
  34. (2008). Pulmonary vascular input impedance is a combined measure of pulmonary vascular resistance and stiffness and predicts clinical outcomes better than pulmonary vascular resistance alone in pediatric patients with pulmonary hypertension,”
  35. (2008). Rapaee et al., “Assessment of global right ventricular function on 64-MDCT compared with MRI,”
  36. (2009). Right heart function in thoracic surgery: role of echocardiography,”
  37. (2005). Right ventricular dyssynchrony in patients with pulmonary hypertension is associated with disease severity and functional class,”Cardiovascular Ultrasound,
  38. (2009). Right ventricular free wall pacing improves cardiac pump function in severe pulmonary arterial hypertension: a computer simulation analysis,”
  39. (2001). Right ventricular ischemia in patients with primary pulmonary hypertension,”
  40. (2008). Role of cardiac magnetic resonance imaging in the management of patients with pulmonary arterial hypertension,”
  41. (2007). S.A.VanWolferen,J.T.Marcus,A.Boonstraetal.,“Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension,”
  42. (2009). Skeletal myoblastsheettransplantationimprovesthediastolicfunction of a pressure-overloaded right heart,”
  43. (2002). Small amounts of α-myosin heavy chain isoform expression significantly increase power output of rat cardiac myocyte fragments,”
  44. Survival in patients with pulmonary arterial hypertension treated with first-line bosentan,”
  45. (2002). Survival in primary pulmonary hypertension: the impact of epoprostenol therapy,”
  46. (2009). The right ventricle in cardiac surgery, a perioperative perspective—I.
  47. (2009). The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension,”
  48. (2010). Timing and magnitude of regional right ventricular function: a speckle trackingderived strainstudy ofnormalsubjects and patients withright ventricular dysfunction,”
  49. (2009). Tissue doppler imaging of right ventricular decompensation in pulmonary hypertension,”
  50. (2009). Tricuspid valve surgery in adults with a dysfunctional systemic right ventricle repair or replace?” Circulation,v o l .
  51. (2009). Trying to succeed when the right ventricle fails,”
  52. (2009). Two-dimensional strain and strain rate imagingofthe rightventricle inadult patients before andafter percutaneous closureofatrialseptaldefects,”European
  53. (2002). u b k a ,E .L .B o l s o n ,J .A .M c D o n a l d ,R .W .M a r t i n
  54. (2004). V.V.McLaughlin,K.W.Presberg,R.L.Doyle etal.,“Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinicalpracticeguidelines,”Chest,vol.126,no.1,pp.78S–92S,